$BLMH.c will continue to execute successful plans. Bloom Health Partners (CSE: BLMH) recently surpassed expectations with its Q2 financial results. The company reported $11.1 million in revenue for the quarter, bringing its total for the first half of 2022 to $16.9 million.
In this recent interview, CEO Andre Morton stated the company is executing the plan it has promised investors. $BLMH.c has provided guidance of $25-$28 million in revenue for this year, which would take its SP to well over $1 based on its P/E ratio at the beginning of this year.
Really excited to watch this company’s performance over the coming months. I’m expecting some highly impressive earnings.
$BLMH.c is currently trading at $.21, valued at $8.2 million.
https://investingnews.com/bloom-health-partners-ceo-andrew-morton/